SPC169

Migalastat eða salt þar af, að meðtöldu hýdróklóríðsaltinu

  • Status:
    Veitt
  • Application date:
    11.11.2016
  • Application published:
    15.12.2016
  • Grant published:
    15.10.2017
  • Max expiry date:
    30.5.2031
  • Medicine name:
    Galafold
  • Medicine for children:
    No

Timeline

Today
11.11.2016Application
15.12.2016Publication
15.10.2017Registration
30.5.2031Expires

Marketing license

  • IS authorization number:
    EU/1/15/1082/001
  • Date:
    14.6.2016
  • Foreign authorization number:
    EU/1/15/1082
  • Date:
    26.5.2016

Owner

  • Name:
    Amicus Therapeutics, Inc.
  • Address:
    1 Cedar Brook Drive, Cranbury, NJ US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents